| Japan Corporate News Network |
|
|
|
|
|
|
|
 |
|
 |
|
| Terumo, Takeda to Co-promote Takeda's Ethical Narcotic Formulations |
|
|
|
Tokyo, Sept 4, 2009 (JCN) - Terumo Corporation and Takeda Pharmaceutical will begin in October the co-promotion of the ethical narcotic formulations that Takeda is manufacturing and marketing in Japan.
Living up to its corporate slogan of "Terumo's unique technology makes medical treatment kinder and gentler," Terumo has made a full-scale entry into the pain relief market for patients of cancer and other diseases, and has set up a task force with twenty members in order to conduct marketing research and education on the proper use of drugs. Terumo would like to pursue the opportunities which will spring forth from its unique strategic approach of relieving the pain of patients.
Takeda has positioned oncology as one of its core therapeutic areas, and it is now expanding the R&D pipeline in that area, as well as enhancing the functions such as research, development, and sales marketing capability globally. In domestic market, Takeda is promoting usage of pain relief therapies for patients with cancer, through manufacturing and marketing of ethical narcotic formulations.
With the two companies co-promoting ethical narcotic formulations which are used for patients with cancer as pain relievers, both parties believe that the medical and scientific information on the relevant products can be shared with an even greater number of healthcare providers so that both companies can further contribute to the pain relieve treatment for patients with cancer.
Copyright © 2010 JCN. All rights reserved. A division of Japan Corporate News Network KK.
 Company Profile |  Print |  Alerts
|
|
|
Terumo, Takeda to Co-promote Takeda's Ethical Narcotic Formulations
(Sept 4, 2009)
|
|
|
XOMA, Takeda Expand Collaboration
(Feb 10, 2009)
|
|
|
Takeda Cuts FY '08 Earnings Forecasts on Stronger Yen
(Nov 5, 2008)
|
|
|
Takeda Ups Half-Year Earnings Estimates
(Oct 20, 2008)
|
|
|
Takeda Established a New Company for Asian Sales & Marketing
(Sept 25, 2008)
|
|
|
Takeda Established a New Company for Clinical Development in the Asia-Oceania Region
(Sept 25, 2008)
|
|
|
Shionogi to Acquire U.S. Drug Maker Sciele Pharma
(Sept 1, 2008)
|
|
|
Takeda Pharmaceutical Raises Earnings Forecast for FY 2008
(July 31, 2008)
|
|
|
Takeda's Tender Offer for U.S. Drug Maker Millennium Ends in Success
(May 9, 2008)
|
|
|
Takeda Sees Operating Profit Drop for 2nd Yr on Swelling Costs
(May 9, 2008)
|
|
|
Recent
Health/Medical
News
|
RSS
|
|
|
|
|
Asahi Kasei Integrates Bioprocess Businesses in North America (Dec 31, 2009)
|
|
|
Asahi Kasei Kuraray Medical Establishes Sales Subsidiary in Korea (Nov 1, 2009)
|
|
|
Asahi Kasei Launches 'Reveal DX' Insertable Cardiac Monitor (Oct 1, 2009)
|
|
|
New RIKEN Robot to Assist in Care Facilities (Sept 29, 2009)
|
|
|
Asahi Kasei Kuraray Medical Building Plant for Therapeutic Apheresis Devices (Sept 25, 2009)
|
|
|
Teijin Develops World's First Bioplastic Eyeglasses (Sept 4, 2009)
|
|
|
Astellas Establishes Fund Laboratory 'Genome Medical Science Laboratory' at the University of Tokyo (Sept 4, 2009)
|
|
|
Kuraray Mediacal Obtains Approval for Artificial Bone Graft (Sept 2, 2009)
|
|
|
Daiichi Sankyo, Ranbaxy Launch Psteoporosis Medication EVISTA in Romania (Sept 2, 2009)
|
|
|
Pfizer and Astellas to Co-promote Hypertension, Hypercholesterolemia Treatment (Aug 31, 2009)
|
More Health/Medical news...
|
|
| |
|
|
|
|
|
